Liliana Elena Weimer | Medicine and Health Sciences | Best Researcher Award

Best Researcher Award

Liliana Elena Weimer
Italian National Institute of Health, Italy
Liliana Elena Weimer
Affiliation Italian National Institute of Health
Country Italy
Google Scholar 2q3g0CAAAAAJ
Documents 128
Citations 2,534
h-index 22
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
Scopus ID 6701388312
ORCID 0000-0002-1554-3150

Liliana Elena Weimer is a medical doctor and clinical researcher with over 30 years of experience in infectious diseases, clinical trials, and global health. Since 2022 she serves as First Researcher (Level II) at the Center for Global Health – Istituto Superiore di Sanità (ISS), Rome, Italy. Her career spans landmark HIV/HCV studies, COVID‑19 surveillance, Long‑COVID coordination, and international collaborations with WHO, the G20, and the American Clinical Trials Group.[1][2]

She has participated in national and multinational cohort studies, public health surveillance programs, and clinical research initiatives focused on infectious diseases and global health. As of September 2026, she has authored or co-authored more than 177 scientific publications and has contributed to research programs involving the American Clinical Trials Group, European collaborative projects, WHO-related activities, and Italian national surveillance systems. Her scholarly profile reflects sustained engagement in evidence-based medicine, public health research, and clinical investigation across several decades.[1][2]

Abstract

This article presents the academic and research profile of Dr. Liliana Elena Weimer, nominated for the Best Researcher Award in recognition of her outstanding contributions to clinical virology, public health surveillance, and international collaborative research. With a career spanning more than three decades at the Italian National Institute of Health (ISS), Dr. Weimer has coordinated national and multinational trials on HIV and HCV, contributed to the PITER cohort (25,000 patients), and led COVID‑19 and Long‑COVID surveillance protocols. Her work is characterised by high‑impact publications, a consistent h‑index of 22, and active engagement in European projects (ORCHESTRA, PREVENT Horizon, SHIELD). The nomination is supported by her record of public competition successes, teaching, and service with Doctors Without Borders.[1]

Keywords

Best Researcher Award, HIV/HCV clinical trials, PITER cohort, COVID‑19 surveillance, Long‑COVID, Malattie Infettive Long Covid, Doctor in Medicine, Infectious Diseases.

Introduction

The Best Researcher Award recognises individuals who demonstrate exceptional scientific output, leadership, and translational impact. Liliana Elena Weimer, MD, has built a distinguished career at the Istituto Superiore di Sanità (ISS), where she has been instrumental in shaping infectious disease research in Italy and beyond. Her work encompasses antiretroviral therapy optimisation, hepatitis C elimination strategies, and the establishment of national surveillance systems for HIV, HCV, and SARS‑CoV‑2. Notably, she is a member of the ISS COVID‑19 National Surveillance Group and the PITER study coordination team, and she contributes to WHO guidelines on Long‑Covid. Her international collaborations and sustained publication record make her a strong candidate for this award.[3]

Research Profile

Dr. Liliana Elena Weimer holds a medical degree from the University of Buenos Aires and a second MD from the University of L’Aquila, with specialisations in Infectious Diseases and Clinical Pharmacology. She has been a researcher at ISS since 1990, winning public competitions for fixed‑term, permanent, and First Researcher positions. Her research profile is characterised by a strong commitment to clinical epidemiology and trial methodology. She has contributed to landmark studies such as ACTG 384/388 (Italy‑USA AIDS trials), the PITER HCV cohort, and the European ORCHESTRA project. She also coordinates the national Long‑COVID surveillance protocol (2021‑2026) funded by the Italian Ministry of Health. With over 128 documents, 2,534 citations, and an h‑index of 22 (Scopus), she maintains a visible presence in the field.[2][4]

  • Senior Clinical Researcher at the Italian National Institute of Health (ISS), Rome.
  • More than three decades of experience in multicenter clinical trials and epidemiological research.
  • Collaborator with international HIV and HCV research networks.
  • Contributor to national SARS-CoV-2 and Long COVID surveillance programs.
  • Participant in European collaborative projects including ORCHESTRA, PREVENT Horizon, SHIELD, EURO-PERISTAT, and JA-05.
  • Member of professional organizations focused on infectious diseases and public health.

Research Contributions

Dr. Liliana Elena Weimer’s contributions are organised around three pillars: clinical trials and cohort studies, public health surveillance, and global health collaborations. She has coordinated over twenty national and international multicentre trials, including the Italian Protease Inhibitors Registry and the NIA surveillance network. As part of the PITER study, she contributed to the largest Italian HCV cohort (25,000 patients), informing treatment strategies for cirrhosis and hepatocellular carcinoma. During the COVID‑19 pandemic, she joined the ISS national surveillance group and collaborated with Bambino Gesù Pediatric Hospital, providing clinical and epidemiological support. She also serves as an external consultant for WHO’s Long‑Covid guidelines and is a member of the Brussels Network of Expertise on Long‑Covid.[5]

Liliana Elena Weimer’s research portfolio encompasses HIV treatment optimization, hepatitis C management, SARS-CoV-2 surveillance, and Long COVID characterization. Her participation in national cohort studies and international clinical trials has contributed to understanding treatment effectiveness, patient outcomes, and disease epidemiology.[1][3]

  • Clinical trials and cohort studies involving HIV therapies.
  • Research on HCV treatment outcomes and long-term virological response.
  • Investigation of monoclonal antibody strategies against emerging SARS-CoV-2 variants.
  • Long COVID symptom characterization and longitudinal follow-up studies.
  • Public health surveillance and antimicrobial resistance research.
  • Support for healthcare access initiatives in resource-limited settings.

Publications

Dr. Liliana Elena Weimer has authored or co‑authored more than 120 peer‑reviewed articles, book chapters, and monographs. Her work appears in high‑impact journals including Hepatology, Children, and Journal of Pediatrics Research Reviews. She received the Best Research Award from the journal Children (IF 2.5) for a study on the clinical characterisation of adolescents with Long‑COVID. She has also published two books on post‑COVID sequelae and SARS‑CoV‑2 variants. Below is a selection of her most cited works:

  • Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, De Santo JL, … Weimer LE (2010). Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology, 52(3):833‑844.
  • George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, … Weimer LE (2009). Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‑year follow‑up of 150 patients. Hepatology, 49(3):729‑738.
  • Saxena V, Nyberg L, Pauly M, Dasgupta A, Nyberg A, Piasecki B, … Weimer LE (2015). Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis. Hepatology, 62(3):715‑725.

Research Impact

With over 2,534 citations and an h‑index of 22, Dr. Liliana Elena Weimer’s work has shaped clinical practice in hepatitis C and HIV care. Her studies on sustained virologic response and long‑term outcomes after HCV therapy are frequently cited in guidelines. She has received multiple recognitions, including an Abstract of Distinction at the AASLD Liver Meeting (2018) and the 2025 Best Research Award from Children journal. She was a Special Invitee to the G20 Health Summit 2023 and serves as a lay judge at the Court of Assizes in Rome. Her impact extends beyond academia: she is a volunteer with Doctors Without Borders (since 1992), providing AIDS therapies in Brazil, and actively participates in public health emergency responses.[1][3]

Award Suitability

The Best Researcher Award recognises sustained excellence, and Dr. Liliana Elena Weimer’s trajectory exemplifies this. She has won three public competitions at the ISS (fixed‑term, permanent, and First Researcher), demonstrating peer‑reviewed career progression. She coordinates the national PITER HCV cohort and the Long‑COVID surveillance protocol, and she has contributed to WHO guidelines. Her publication record includes landmark articles in hepatology, and she has received journal‑level awards for her work on Long‑COVID. Her international collaborations with the American Clinical Trials Group, INSERM, and the European Commission place her among the leading clinical researchers in Italy. This award would further acknowledge her role in translating research into public health action.[4]

Conclusion

Dr. Liliana Elena Weimer is a medical researcher of high calibre, with a career that bridges clinical trials, epidemiological surveillance, and global health equity. Her work on HIV, HCV, and COVID‑19 has informed national and international guidelines, and her commitment to service—through Doctors Without Borders and public health emergencies—distinguishes her as a compassionate and effective leader. The data presented—128 documents, 2,534 citations, h‑index 22, and consistent recognition—support her nomination for the Best Researcher Award. Her profile aligns with the core values of the award: scientific rigor, translational impact, and dedication to improving human health.[5]

References

  1. Scopus. (n.d.). Author details: Weimer, Liliana Elena, Author ID 6701388312. Scopus Preview.https://www.scopus.com/pages/authors/6701388312
  2. Google Scholar. (n.d.). Liliana Elena Weimer – citations & h‑index. Google Scholar.https://scholar.google.co.uk/citations?user=2q3g0CAAAAAJ
  3. Morgan, T. R., Ghany, M. G., Kim, H. Y., Snow, K. K., Shiffman, M. L., De Santo, J. L., … & Weimer, L. E. (2010). Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology, 52(3), 833‑844. https://doi.org/10.1002/hep.23744
  4. George, S. L., Bacon, B. R., Brunt, E. M., Mihindukulasuriya, K. L., Hoffmann, J., … & Weimer, L. E. (2009). Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‑year follow‑up of 150 patients. Hepatology, 49(3), 729‑738. https://doi.org/10.1002/hep.22694
  5. Saxena, V., Nyberg, L., Pauly, M., Dasgupta, A., Nyberg, A., Piasecki, B., … & Weimer, L. E. (2015). Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis. Hepatology, 62(3), 715‑725. https://doi.org/10.1002/hep.27922

Alessandro Orlando | Medicine and Health Sciences | Best Researcher Award

Best Researcher Award

Alessandro Orlando
Center for Trauma and Acute Care Surgery Research, HCA Healthcare,  United States
Alessandro Orlando
Affiliation Center for Trauma and Acute Care Surgery Research, HCA Healthcare
Country United States
Scopus ID 48861826200
Documents 50
Citations 548
h-index 14
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
Google Scholar ZGMH340AAAAJ

Alessandro Orlando is a clinical epidemiologist, research leader, educator, and healthcare scientist affiliated with HCA Healthcare in the United States. His work focuses on clinical epidemiology, trauma research, evidence-based medicine, predictive modeling, traumatic brain injury outcomes, and translational healthcare research. Over a professional career spanning more than sixteen years, Orlando has contributed to multicenter clinical investigations, epidemiologic methodology, trauma system research, and healthcare quality improvement initiatives. His scholarly output and leadership activities have supported the advancement of trauma care and clinical decision-making in diverse healthcare settings.[1]

Abstract

This article presents a scholarly overview of Alessandro Orlando’s academic background, professional achievements, research contributions, teaching activities, and scientific impact within medicine and health sciences. His work integrates epidemiological methods, trauma outcomes research, multicenter clinical investigations, and predictive analytics to improve patient care and healthcare decision-making. Through leadership positions in trauma research organizations and HCA Healthcare, he has contributed to the development of collaborative research infrastructures and evidence-based clinical practices.[1]

Keywords

Clinical Epidemiology; Trauma Research; Evidence-Based Medicine; Health Outcomes; Predictive Modeling; Machine Learning; Traumatic Brain Injury; Multicenter Studies; Population Health; Healthcare Research Leadership.

Introduction

Alessandro Orlando is recognized for his contributions to clinical epidemiology and trauma research. His academic preparation includes a PhD in Clinical Epidemiology from Johns Hopkins University, a Master of Public Health in Epidemiology from Virginia Commonwealth University, and a Bachelor of Science in Biology. His research career has been characterized by a sustained commitment to improving healthcare outcomes through rigorous methodological approaches, multicenter collaborations, and translational clinical investigations.[1]

His work has spanned trauma systems, neurosurgical outcomes, epidemiologic study design, healthcare analytics, and the implementation of evidence-based research frameworks within complex healthcare organizations. These activities have positioned him as a contributor to both academic and applied clinical research environments.[2]

Research Profile

As Assistant Vice President at the HCA Healthcare Center for Trauma and Acute Care Surgery Research, Orlando directs research strategy, project implementation, and multidisciplinary collaboration. His responsibilities include oversight of multicenter trauma studies, management of research portfolios, and coordination of scientific dissemination activities. He has contributed to increased scholarly productivity through abstracts, manuscripts, conference presentations, and multicenter investigations involving trauma centers across the United States.[1]

  • Clinical epidemiology and outcomes research.
  • Traumatic brain injury and neurosurgical decision support.
  • Clinical prediction model development and validation.
  • Application of machine learning in healthcare.
  • Multicenter trauma and acute care surgery research.
  • Research transparency and clinical data integrity.

Research Contributions

Orlando’s research portfolio demonstrates contributions to pulmonary complications, trauma systems, neurosurgical outcomes, emergency care pathways, and clinical intervention assessment. He has participated in large multicenter observational and interventional studies that have informed clinical practice and healthcare delivery. His work frequently emphasizes methodological rigor, real-world clinical applicability, and patient-centered outcomes.[2]

In addition to publication activities, Orlando has contributed to the development of research infrastructure through management of clinical databases and implementation of standardized systems for research governance and project oversight. Such initiatives support reproducibility, transparency, and operational efficiency in clinical research programs.[1]

Publications

Among Alessandro Orlando’s most influential publications are the multicenter POPULAR study on post-anaesthesia pulmonary complications, a randomized tramadol efficacy trial, and investigations of traumatic brain injury management and thrombectomy protocols, collectively contributing to evidence-based clinical practice and patient outcomes.[2][3][4][5]

Selected publications associated with Alessandro Orlando include highly cited contributions in respiratory medicine, urology, neurosurgery, and neurointerventional science.[2][3]

  1. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study, The Lancet Respiratory Medicine, 2019.
  2. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet, European Urology, 2012.
  3. Outcomes of a nontransfer protocol for mild traumatic brain injury with abnormal head computed tomography in a rural hospital setting, World Neurosurgery, 2014.
  4. A standardized neurointerventional thrombectomy protocol leads to faster recanalization times, Journal of NeuroInterventional Surgery, 2017.

Research Impact

The documented Scopus profile indicates a publication record of 50 indexed documents, 548 citations, and an h-index of 14, reflecting measurable influence within the biomedical research community.[1]

Beyond publication metrics, Orlando’s impact is reflected through mentoring activities, graduate-level teaching appointments at Johns Hopkins University, invited lectures on epidemiologic methods, and peer-review service for scientific journals including Frontiers in Neurology and Neurotrauma Reports. These activities contribute to the dissemination of methodological expertise and the advancement of clinical research standards.[4]

Award Suitability

Alessandro Orlando’s profile demonstrates several characteristics commonly associated with academic recognition in research excellence programs. These include sustained scholarly productivity, leadership of multicenter clinical investigations, development of research infrastructure, competitive academic funding support, peer-review service, graduate-level teaching experience, and contributions to evidence-based medicine.[1]

His integration of epidemiologic science with trauma care research, together with his commitment to collaborative healthcare innovation, aligns with the objectives of professional awards that recognize impactful research, educational contributions, and advancement of healthcare knowledge.[2]

Conclusion

Alessandro Orlando has established a multidisciplinary career at the intersection of clinical epidemiology, trauma research, and healthcare innovation. His contributions encompass scientific publication, research leadership, education, peer review, and multicenter collaboration. The available evidence indicates a sustained commitment to improving patient outcomes through evidence-based methodologies and clinically relevant research initiatives. Collectively, these accomplishments provide a substantive basis for consideration within professional research recognition programs such as the Best Researcher Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Alessandro Orlando, Author ID 48861826200. Scopus. https://www.scopus.com/pages/authors/48861826200
  2. Kirmeier, E., Eriksson, L. I., Lewald, H., Fagerlund, M. J., Hoeft, A., Hollmann, M., et al. (2019). Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. The Lancet Respiratory Medicine, 7(2), 129–140. DOI: https://doi.org/10.1016/S2213-2600(18)30294-7
  3. Bar-Or, D., Salottolo, K. M., Orlando, A., Winkler, J. V., et al. (2012). A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of acute pain. European Urology, 61(4), 736–743. DOI: https://doi.org/10.1016/j.eururo.2011.08.039
  4. Levy, A. S., Orlando, A., Salottolo, K., Mains, C. W., & Bar-Or, D. (2014). Outcomes of a nontransfer protocol for mild traumatic brain injury with abnormal head computed tomography in a rural hospital setting. World Neurosurgery, 82(1–2), e319–e323. DOI: https://doi.org/10.1016/j.wneu.2013.11.008
  5. Frei, D., McGraw, C., McCarthy, K., Whaley, M., Bellon, R. J., Loy, D., Wagner, J., et al. (2017). A standardized neurointerventional thrombectomy protocol leads to faster recanalization times. Journal of NeuroInterventional Surgery, 9(11), 1035–1040. DOI: https://doi.org/10.1136/neurintsurg-2016-012716

Benjamin Ajibade | Nursing and Health Professions | Innovative Research Award

Innovative Research Award

Benjamin Ajibade
Northumbria University, United Kingdom
Benjamin Ajibade
Affiliation Northumbria University
Country United Kingdom
Scopus ID 57355622100
Documents 12
Citations 48
h-index 3
Subject Area Nursing and Health Professions
Event Top Teachers Awards
ORCID 0000-0002-0204-4205
Google Scholar MiIjB38AAAAJ

Benjamin Ajibade is a mental health nursing academic, researcher, educator, and institutional leader affiliated with Northumbria University in the United Kingdom. His academic profile combines extensive clinical nursing experience, higher education leadership, doctoral supervision, curriculum innovation, inclusive teaching practice, and interdisciplinary research. His scholarly contributions have focused on nursing education, mental health, equity and inclusion, international student experiences, healthcare access, dementia care, and culturally responsive educational methodologies including LEGO® Serious Play®.[1]

With more than three decades of combined clinical and academic experience, Benjamin Ajibade has contributed to nursing scholarship through peer-reviewed publications, conference presentations, research supervision, editorial service, external examining activities, grant-funded projects, and leadership of initiatives aimed at widening participation and advancing equity within higher education and healthcare systems.[1]

Abstract

This article presents an academic overview of Benjamin Ajibade’s professional achievements, scholarly contributions, educational leadership, research supervision, community engagement, and service to nursing education. Particular attention is given to his work in mental health nursing, inclusion and diversity initiatives, international student transition research, doctoral supervision, curriculum innovation, and externally funded projects. The profile also evaluates his suitability for recognition through the Innovative Research Award associated with the Top Teachers Awards based on documented evidence of academic leadership, research activity, educational innovation, and professional impact.[1]

Keywords

Mental Health Nursing; Nursing Education; Higher Education; Inclusivity; Equity and Diversity; LEGO® Serious Play®; Doctoral Supervision; Curriculum Development; Healthcare Research; International Students; Dementia Care; Research Leadership; Community Engagement; Educational Innovation.

Introduction

Benjamin Ajibade serves as Assistant Professor in Mental Health Nursing within the Department of Nursing, Midwifery and Health at Northumbria University. His career spans clinical nursing, healthcare management, academic leadership, teaching, research, and professional service. Throughout his career he has worked across multiple healthcare and higher education institutions in both Nigeria and the United Kingdom, contributing to nursing practice, professional development, educational innovation, and evidence-informed healthcare delivery.[1]

His academic interests encompass mental health nursing, public health, research methodologies, healthcare equity, educational transitions, student wellbeing, dementia care, and decolonisation of curricula. These themes are reflected in his scholarly outputs, funded projects, conference presentations, doctoral supervision activities, and leadership roles within national and international educational networks.[1]

Research Profile

Benjamin Ajibade completed a Professional Doctorate in Nursing at the University of Sunderland, where his doctoral thesis investigated sociocultural factors influencing Nigerian nursing students transitioning into UK higher education through the application of LEGO® Serious Play® methodology. This research established a foundation for subsequent scholarly work concerning international student experiences, belonging, educational transitions, and inclusive pedagogical practice.[2]

His research portfolio demonstrates engagement with mental health, educational equity, public health, ageing, dementia, healthcare access, minority ethnic experiences, postgraduate research participation, and anti-racist educational practices. He has also contributed to collaborative projects funded through national and institutional initiatives focused on inclusion, healthcare access, and postgraduate researcher development.[1]

  • Institutional Lead for the Pro:NE project.
  • Principal and co-investigator on multiple healthcare and educational research initiatives.
  • Supervisor of undergraduate, postgraduate, professional doctorate, and PhD research.
  • Contributor to equality, diversity, and inclusion scholarship.
  • Researcher in nursing education and international student transitions.

Research Contributions

A notable aspect of Benjamin Ajibade’s scholarly contribution is the application of innovative educational methodologies to investigate complex sociocultural experiences. His work using LEGO® Serious Play® methodology has explored student transitions, learning experiences, and inclusion within higher education settings. Such research has contributed to broader discussions concerning student engagement, belonging, and educational equity.[2]

His contributions also extend to healthcare service accessibility and health equity research. Publications addressing reproductive health access barriers, minority ethnic healthcare experiences, dementia care, and postgraduate research participation demonstrate an interdisciplinary approach that integrates education, nursing, and public health perspectives.[4]

  • Research on educational transitions among international nursing students.
  • Studies promoting inclusivity and decolonisation in nursing education.
  • Projects addressing healthcare access among minoritised communities.
  • Research leadership in postgraduate researcher development initiatives.
  • Development of evidence-informed educational practices and mentorship frameworks.

Publications

Benjamin Ajibade’s most cited publications examine patient-centred care planning, international nursing student transitions, and innovative LEGO® Serious Play® methodology, contributing to nursing education, inclusion, and healthcare access research.[2][3][4][5]

Ajibade’s publication record includes peer-reviewed journal articles, conference papers, preprints, educational research outputs, and collaborative healthcare studies. Several publications have addressed nursing practice, international education, healthcare access, and student wellbeing.[2][3][4]

Research Impact

The documented impact of Benjamin Ajibade’s work can be observed across research, teaching, supervision, policy engagement, and professional practice. His funded projects have supported work on healthcare inclusion, culturally responsive care, postgraduate researcher development, and educational equity. He has also supervised substantial numbers of undergraduate and postgraduate students and has contributed to doctoral supervision, examination, and mentoring activities.[1]

Beyond formal research outputs, his leadership within equality and diversity initiatives, editorial responsibilities, external examiner appointments, validation panels, and healthcare stakeholder collaborations demonstrates broader academic influence extending beyond institutional boundaries.[1]

Award Suitability

Benjamin Ajibade’s profile demonstrates multiple characteristics commonly associated with academic recognition for innovative research and educational leadership. These include sustained engagement with research-informed teaching, innovative methodological approaches, leadership of externally funded projects, commitment to equity and inclusion, doctoral supervision, international academic collaboration, and dissemination of scholarship through publications and conferences.[1]

His use of LEGO® Serious Play® methodology in higher education research, leadership of initiatives supporting minoritised postgraduate researchers, involvement in healthcare equity projects, and contributions to curriculum transformation collectively provide evidence of innovation and impact within nursing education and healthcare scholarship.[3][5]

Conclusion

Benjamin Ajibade represents a scholar-practitioner whose career integrates nursing practice, higher education leadership, inclusive pedagogy, research supervision, and interdisciplinary scholarship. His contributions to mental health nursing education, educational equity, healthcare inclusion, and international student research have established a record of professional achievement and academic service. The available evidence indicates a sustained commitment to advancing knowledge, supporting learners, and promoting equitable healthcare and educational environments, supporting consideration for recognition through the Innovative Research Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Benjamin Ajibade, Author ID 57355622100. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57355622100
  2. Ajibade, B. (2021). Assessing the patient’s needs and planning effective care. British Journal of Nursing, 30(20), 1166-1171. DOI: https://doi.org/10.12968/bjon.2021.30.20.1166
  3. Ajibade, B.O., & Hayes, C. (2022). Using LEGO® Serious Play® Methodology in supporting Nigerian nursing students’ sociocultural transitions to UK higher education. Nurse Education Today, 119, 105582. DOI: https://doi.org/10.1016/j.nedt.2022.105582
  4. Ajibade, B., Oguguo, C., Ling, J., & Eberhardt, J. (2022). Recommendations for removing access barriers to effective sexual/reproductive health services for young people in South East Nigeria: A systematic review. International Journal of Sexual and Reproductive Health Care. https://research.tees.ac.uk/ws/portalfiles/portal/55499093/IJSRHC_5_137.pdf
  5. Ajibade, B.O., & Hayes, C. (2020). An insight into utilising LEGO® Serious Play® to explore international student transitions into a UK higher education institution. SAGE Publications Ltd. https://scholar.google.com/citations?user=MiIjB38AAAAJ&hl=en&oi=sra

Saksham Kohli | Health Professions | Best Researcher Award

Best Researcher Award

Saksham Kohli
Cook County Health

Saksham Kohli
Affiliation Cook County Health
Country United States
Scopus ID 59495632900
Documents 52
Citations 4
Subject Area Health Professions
Event Top Teachers Awards
ORCID 0000-0001-6983-1804

The Best Researcher Award recognition highlights the scholarly activities and emerging research contributions of Saksham Kohli at Cook County Health. Working within the field of Health Professions, Saksham Kohli has contributed to studies involving gastroenterology, hepatology, nephrology, and healthcare outcomes research. Recent publications demonstrate engagement with evidence-based clinical investigations addressing inpatient outcomes, quality improvement methodologies, readmission patterns, and patient survival analyses.[1] Through interdisciplinary research and participation in contemporary clinical studies, Saksham Kohli has supported the advancement of knowledge relevant to healthcare quality, patient management, and population-level medical outcomes.[2]

Abstract

This article presents an academic overview of Saksham Kohli and the research profile associated with recognition under the Best Researcher Award category. The researcher’s recent scholarly output focuses on clinical outcomes, gastrointestinal diseases, healthcare quality assessment, and patient-centered investigations. Published studies have addressed metabolic dysfunction-associated liver disease, endoscopy performance evaluation, alcoholic hepatitis readmissions, and survival considerations among elderly dialysis patients.[2]

Keywords

Health Professions, Gastroenterology, Clinical Outcomes Research, Healthcare Quality Improvement, Hepatology, Readmission Studies, Evidence-Based Medicine.

Introduction

Healthcare research plays a significant role in improving clinical practice, patient outcomes, and healthcare system efficiency. Researchers working across medical specialties contribute to evidence generation that supports informed decision-making and policy development. Saksham Kohli’s published work reflects participation in studies examining disease burden, treatment outcomes, healthcare utilization, and quality improvement initiatives within contemporary clinical settings.[3]

Research Profile

Affiliated with Cook County Health in the United States, Saksham Kohli has developed a research profile centered on applied clinical investigations. Indexed under Scopus Author ID 59495632900, the researcher has contributed to publications spanning gastroenterology, hepatology, nephrology, and healthcare analytics. These studies demonstrate engagement with real-world healthcare datasets and outcome-oriented medical research.[1]

Research Contributions

The research contributions of Saksham Kohli include analyses of metabolic-dysfunction-associated steatotic liver disease and its impact on inpatient outcomes, assessments of endoscope tip angulation performance, nationwide evaluations of alcoholic hepatitis readmissions, and investigations involving elderly dialysis populations.[2] These studies contribute to clinical understanding by examining patient outcomes, healthcare quality metrics, and disease management strategies using quantitative methodologies.[4]

Publications

  • Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes.
  • Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
  • Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
  • Octogenarians on Dialysis; Navigating Survival Amidst Struggles.

Research Impact

The available publication record demonstrates contributions to clinically relevant topics affecting patient care and healthcare delivery. Research addressing liver disease outcomes, readmission risk factors, endoscopic performance, and nephrology-related survival outcomes provides useful evidence for healthcare professionals and researchers seeking to improve treatment effectiveness and quality standards.[5]

Award Suitability

Saksham Kohli’s profile aligns with the objectives of the Best Researcher Award through demonstrated scholarly engagement, publication activity, and contributions to healthcare research. The combination of outcome-based studies, quality improvement initiatives, and multidisciplinary clinical investigations reflects an active commitment to advancing medical knowledge and evidence-based practice.[1]

Conclusion

Saksham Kohli has contributed to a growing body of healthcare research through studies addressing important clinical and quality-of-care challenges. The published work demonstrates involvement in contemporary medical investigations and supports the dissemination of evidence relevant to patient outcomes, healthcare systems, and disease management. These accomplishments provide a foundation for recognition within academic and professional research communities.

References

  1. Elsevier. (n.d.). Scopus author details: Saksham Kohli, Author ID 59495632900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59495632900
  2. Kohli, S. et al. (2026). Impact of MASLD and MASH on Clostridioides difficile Inpatient Outcomes.
    https://doi.org/10.3390/gastroent17020038
  3. Kohli, S. et al. (2026). Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
    https://doi.org/10.1055/a-2877-9452
  4. Kohli, S. et al. (2026). Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
    https://doi.org/10.3390/gidisord8020027
  5. Kohli, S. et al. (2025). Octogenarians on Dialysis; Navigating Survival Amidst Struggles.
    https://doi.org/10.34172/jnp.2024.21476
  6. Top Teachers Awards. (n.d.). Best Researcher Award Recognition Program.
    topteachers.net

Zeynep Karaman Özlü | Nursing and Health Professions | Best Researcher Award

Best Researcher Award

Zeynep Karaman Özlü
Atatürk University, Türkiye
Zeynep Karaman Özlü
Affiliation Atatürk University
Country Turkey
Scopus ID 36677390200
Documents 40
Citations 480
h-index 11
Subject Area Nursing and Health Professions
Event Top Teachers Awards
ORCID 0000-0001-8896-5461
Google Scholar 9s_Dk3kAAAAJ

Zeynep Karaman Özlü is a Turkish nursing scholar, educator, administrator, and researcher affiliated with Atatürk University. Her academic career encompasses surgical nursing, perioperative care, patient safety, intensive care nursing, healthcare quality, accreditation, and emerging applications of artificial intelligence in healthcare. Through research, teaching, leadership activities, international collaborations, and scientific service contributions, she has developed a multidisciplinary academic profile recognized within nursing and health sciences communities.[1]

Abstract

This article summarizes the academic achievements, research activities, teaching contributions, leadership responsibilities, and scholarly impact of Professor Zeynep Karaman Özlü. Her work primarily focuses on surgical nursing, perioperative care, patient safety, healthcare quality, intensive care nursing, and evidence-based clinical practice. Her scholarly portfolio demonstrates continuous engagement in education, research, international collaboration, and healthcare innovation within nursing sciences.[1]

Keywords

Surgical Nursing, Perioperative Nursing, Patient Safety, Intensive Care Nursing, Nursing Education, Healthcare Quality, Accreditation, Clinical Research Nursing, Artificial Intelligence in Healthcare, Health Services Research.

Introduction

Professor Zeynep Karaman Özlü has served Atatürk University through academic, administrative, educational, and research-oriented roles. Beginning her academic progression as a research assistant and advancing to full professor, she has contributed to curriculum development, postgraduate supervision, institutional quality initiatives, accreditation processes, scientific evaluation activities, and international research networks. Her academic background includes master’s and doctoral studies in surgical nursing, forming the foundation for a sustained research career focused on improving healthcare outcomes and nursing practice.[1]

Research Profile

The research profile of Zeynep Karaman Özlü integrates clinical nursing research, healthcare quality management, patient-centered care, intensive care practice, surgical recovery, psychological adaptation, and healthcare innovation. She has participated in European COST Actions, contributed to multidisciplinary projects, reviewed national research proposals, and supported quality assurance initiatives within higher education and healthcare systems. Her research areas increasingly include digital transformation and artificial intelligence applications relevant to healthcare delivery and nursing education.[1]

Research Contributions

Research contributions include advancing perioperative nursing practice, improving postoperative patient care, validating clinical assessment instruments, investigating psychological resilience among healthcare professionals, evaluating anxiety management interventions, promoting patient safety frameworks, supporting healthcare quality accreditation, strengthening nursing education methodologies, integrating evidence-based practice into clinical environments, and encouraging responsible innovation in healthcare technologies.[1]

Publications

Selected publications demonstrate contributions to postoperative recovery, psychological adaptation, clinical measurement validation, patient well-being, and nursing assessment methodologies. These studies have addressed pain management, resilience during public health emergencies, surgical fear assessment, relaxation interventions, and sleep evaluation in clinical populations.[2][3][4][5][6]

  • Effect of music on postoperative pain and physiologic parameters of patients after open heart surgery.
  • The effect of the fear of COVID-19 on healthcare professionals’ psychological adjustment skills.
  • Validation of the Turkish version of the Surgical Fear Questionnaire.
  • Progressive muscle relaxation exercises and outcomes among patients with COVID-19.
  • Richard Campbell Sleep Scale validity and reliability study.

Research Impact

With 40 indexed documents, approximately 480 citations, and an h-index of 11, the scholarly record reflects measurable influence within nursing and health sciences literature. Research outputs have contributed to evidence-based nursing practice, clinical assessment, perioperative care improvement, psychological support strategies, and healthcare quality enhancement. Citation activity indicates continuing relevance across educational, clinical, and research settings.[1]

Award Suitability

The profile demonstrates qualifications commonly associated with academic recognition programs through sustained scholarly productivity, leadership in quality and accreditation initiatives, participation in international research collaborations, supervision and teaching across educational levels, scientific reviewing responsibilities, healthcare innovation activities, and documented research impact. These achievements collectively support consideration for recognition within research and higher education award frameworks.[1]

Conclusion

Zeynep Karaman Özlü represents an established academic contributor within nursing and health professions. Her record combines clinical research, educational leadership, quality assurance, international collaboration, and professional service. The breadth of activities documented across research, teaching, administration, and healthcare innovation illustrates a comprehensive academic career with continuing contributions to nursing science and healthcare improvement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zeynep Karaman Özlü, Author ID 36677390200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=36677390200
  2. Özer N., Özlü Z.K., Arslan S., Günes N. (2010). Effect of music on postoperative pain and physiologic parameters of patients after open heart surgery. Pain Management Nursing. https://doi.org/10.1016/j.pmn.2010.05.002
  3. Secer I., Ulaş S., Karaman-Özlü Z. (2020). The effect of the fear of COVID-19 on healthcare professionals’ psychological adjustment skills: mediating role of experiential avoidance and psychological resilience. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2020.561536
  4. Bağdigen M., Özlü Z.K. (2017). Validation of the Turkish version of the Surgical Fear Questionnaire. Journal of PeriAnesthesia Nursing. https://doi.org/10.1016/j.jopan.2017.05.007
  5. Özlü I., Öztürk Z., Karaman Özlü Z., Tekin E., Gür A. (2021). The effects of progressive muscle relaxation exercises on the anxiety and sleep quality of patients with COVID-19: A randomized controlled study. Perspectives in Psychiatric Care. https://doi.org/10.1111/ppc.12750
  6. Özlü Z.K., Özer N. Richard Campbell Sleep Scale Validity and Reliability Study. Journal of Turkish Sleep Medicine. 10.4274/jtsm.02.008

Timea Claudia Ghitea | Medicine and Health Sciences | Women Researcher Award

Women Researcher Award

Timea Claudia Ghitea
University of Oradea, Romania
Timea Claudia Ghitea
Affiliation University of Oradea
Country Romania
Scopus ID 57214826600
Documents 103
Citations 722
h-index 15
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0001-8981-1958
Google Scholar VsFBqbQAAAAJ

Timea Claudia Ghitea is a Romanian academic, pharmacist, nutrition specialist, and university educator affiliated with the Faculty of Medicine and Pharmacy at the University of Oradea. Her scholarly activities integrate clinical nutrition, metabolic disorders, dietetics, rehabilitation medicine, pharmaceutical sciences, and public health research. Through academic teaching, clinical practice, and scientific publication, she has contributed to advancing evidence-based nutritional interventions and multidisciplinary healthcare approaches. Her research profile demonstrates sustained engagement in metabolic syndrome, diabetes, probiotics, sarcopenia, rehabilitation outcomes, and maternal health studies.[1][2]

Abstract

This article summarizes the academic achievements, professional experience, research output, and scientific impact of Timea Claudia Ghitea. Her work spans medicine, pharmacy, nutrition science, and metabolic health, with particular emphasis on evidence-based dietary interventions and patient-centered healthcare. Through extensive publication activity and interdisciplinary collaboration, she has contributed to contemporary understanding of chronic disease management, rehabilitation nutrition, and probiotic-based therapeutic approaches.[1]

Keywords

Clinical Nutrition, Dietetics, Metabolic Syndrome, Diabetes Mellitus, Probiotics, Sarcopenia, Rehabilitation Medicine, Pharmacy, Biomedical Sciences, Public Health, Farmacie, Nutriție, Stiinte Biomedicale, Microbiommi, Microbiologie, General & Internal Medicine, Research & Experimental Medicine, Biochemistry & Molecular Biology, Health Care Sciences & Services, Nutrition & Dietetics.

Introduction

Timea Claudia Ghitea has developed a multidisciplinary career combining pharmaceutical practice, academic instruction, nutrition consultancy, and biomedical research. Since 2017 she has served as University Assistant at the Faculty of Medicine and Pharmacy, University of Oradea, while simultaneously practicing as a clinical and sports nutritionist. Her educational background includes degrees in biology, chemistry, pharmacy, cell biology, and a PhD in Biomedical Sciences with specialization in clinical and sports nutrition, providing a comprehensive foundation for translational healthcare research.[1]

Research Profile

The research profile of Timea Claudia Ghitea reflects sustained scholarly productivity in medicine and health sciences, supported by more than one hundred indexed publications, substantial citation activity, and an established h-index. Her investigations focus on nutrition-related interventions, metabolic disorders, gastrointestinal microbiota, pharmaceutical sciences, rehabilitation outcomes, and clinical management strategies for chronic diseases. The interdisciplinary nature of her work facilitates collaboration among physicians, pharmacists, nutritionists, and public health researchers.[1][2]

Research Contributions

  • Advanced understanding of probiotic and prebiotic applications in metabolic syndrome and type 2 diabetes management.[3]
  • Contributed to evidence regarding nutritional therapy for sarcopenia associated with immobilization and chronic disease conditions.[6]
  • Investigated dietary intervention strategies influencing sarcopenic indicators among patients with metabolic syndrome.[7]
  • Supported multidisciplinary studies examining rehabilitation outcomes and prevention of secondary complications following spinal cord injury.[5]
  • Participated in comprehensive reviews addressing maternal health and antiphospholipid syndrome during pregnancy.[4]

Publications

Notable publications include research on gut microbiota and metabolic disease, pregnancy-related autoimmune disorders, rehabilitation medicine, nutrition-based interventions for sarcopenia, and metabolic syndrome management. These studies collectively demonstrate a commitment to translational healthcare research with practical clinical applications.[3][4][5][6][7]

  1. Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium.
  2. Antiphospholipid Syndrome in Pregnancy: A Comprehensive Literature Review.
  3. The Outcomes of Robotic Rehabilitation Assisted Devices Following Spinal Cord Injury and the Prevention of Secondary Associated Complications.
  4. The Contribution of Diet Therapy and Probiotics in the Treatment of Sarcopenia Induced by Prolonged Immobilization Caused by the COVID-19 Pandemic.
  5. The Influence of Diet Therapeutic Intervention on the Sarcopenic Index of Patients with Metabolic Syndrome.

Research Impact

With 103 indexed documents, 722 citations, and an h-index of 15, Timea Claudia Ghitea has established a measurable academic presence within medicine and health sciences. Her publications have contributed to contemporary discussions regarding nutrition-based therapeutic approaches, metabolic disease management, rehabilitation medicine, and clinical healthcare optimization. The citation performance of her work indicates ongoing scholarly engagement and relevance within multiple biomedical disciplines.[1]

Award Suitability

Timea Claudia Ghitea demonstrates several characteristics commonly associated with recognition through a Women Researcher Award. These include sustained publication productivity, interdisciplinary scientific contributions, active involvement in academic teaching, leadership in healthcare practice, mentorship activities, professional society memberships, and research addressing significant public health challenges. Her integration of clinical practice and academic scholarship illustrates a model of translational research with practical societal relevance.[1][2]

Conclusion

Timea Claudia Ghitea has built a distinguished academic and professional career spanning pharmacy, nutrition, medicine, and health sciences. Her research contributions, publication record, educational achievements, and clinical expertise collectively demonstrate a sustained commitment to advancing evidence-based healthcare. These accomplishments support her profile as a noteworthy contributor to biomedical research and higher education.

References

  1. Elsevier. (n.d.). Scopus author details: Timea Claudia Ghitea, Author ID 57214826600. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57214826600
  2. ORCID. (n.d.). Timea Claudia Ghitea researcher profile. https://orcid.org/0000-0001-8981-1958
  3. TC Ghitea et al. Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium. Microorganisms. https://doi.org/10.3390/microorganisms9030618
  4. TC Ghitea et al. Antiphospholipid Syndrome in Pregnancy: A Comprehensive Literature Review. BMC Pregnancy and Childbirth. https://link.springer.com/article/10.1186/s12884-025-07471-w
  5. TC Ghitea et al. The Outcomes of Robotic Rehabilitation Assisted Devices Following Spinal Cord Injury and the Prevention of Secondary Associated Complications. Medicina. https://doi.org/10.3390/medicina58101447
  6. TC Ghitea et al. The Contribution of Diet Therapy and Probiotics in the Treatment of Sarcopenia Induced by Prolonged Immobilization Caused by the COVID-19 Pandemic. Nutrients. https://doi.org/10.3390/nu14214701
  7. Ghitea TC et al. The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome. Acta Endocrinologica. https://pmc.ncbi.nlm.nih.gov/articles/PMC8126402/

Ömer Yavuz | Medicine and Health Sciences | Excellence in Research Award

Excellence in Research Award

Ömer Yavuz
Başakşehir Çam and Sakura City Hospital, Turkey
Ömer Yavuz
Affiliation Başakşehir Çam and Sakura City Hospital
Country Turkey
Scopus ID 56712503200
Documents 11
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event Top Teachers Awards

Ömer Yavuz is a thoracic surgery specialist affiliated with Başakşehir Çam and Sakura City Hospital. He has contributed significantly to thoracic surgery research through clinical investigations, minimally invasive surgical innovations, oncological studies, and multidisciplinary collaborations.[1] His academic profile reflects active participation in peer-reviewed publications, international scientific congresses, educational activities, and collaborative healthcare research initiatives within thoracic and pulmonary medicine. The Excellence in Research Award recognizes his distinguished scholarly achievement, sustained scientific contribution, and professional advancement in the field of medicine and health sciences.[2]

Abstract

Ömer Yavuz is a Turkish thoracic surgery specialist whose academic activities encompass clinical thoracic surgery, pulmonary oncology, minimally invasive surgical procedures, robotic thoracic surgery, and perioperative patient management. His scholarly contributions include peer-reviewed journal publications, conference presentations, collaborative multicenter studies, and educational involvement in thoracic surgery seminars.[3] His research portfolio demonstrates continuing engagement with contemporary surgical techniques and evidence-based clinical practice, particularly in lung cancer surgery, thoracic oncology, port catheter applications, and minimally invasive approaches.[4]

Keywords

Thoracic Surgery, Lung Cancer, Robotic Surgery, Pulmonary Oncology, Minimally Invasive Surgery, Thoracic Oncology, Video-Assisted Thoracoscopic Surgery, Surgical Research, Medical Education, Clinical Research.

Introduction

Thoracic surgery remains an essential subspecialty within medicine, requiring the integration of surgical precision, oncological knowledge, and multidisciplinary clinical coordination. Research in this field contributes to the advancement of minimally invasive interventions, perioperative management, and improved long-term patient outcomes. Within this context, Ömer Yavuz has participated in clinical and academic activities addressing thoracic surgical practice, lung cancer management, robotic-assisted procedures, and rare thoracic disorders.[5]

His professional training includes medical education at Gülhane Military Medical Faculty and specialization in thoracic surgery at Gülhane Military Medical Academy Haydarpaşa Training Hospital. Subsequent clinical appointments at Muş State Hospital, Koç University Hospital, and Başakşehir Çam and Sakura City Hospital contributed to the development of his clinical and academic profile.[6]

Research Profile

The research profile of Ömer Yavuz reflects interdisciplinary collaboration across thoracic surgery, oncology, pathology, and minimally invasive surgical technologies. His publications include clinical analyses, surgical case reports, retrospective investigations, translational research studies, and conference proceedings focused on thoracic diseases and operative outcomes.[7]

Research topics addressed in his work include pectus excavatum surgery, pleurodesis techniques, thoracic oncology, spread through air spaces in lung adenocarcinoma, immune profiling after minimally invasive lobectomy, robotic thoracic surgery, port catheter complications, and bibliometric analyses of surgical literature.[8]

In addition to publication activities, he has participated in national and international scientific congresses, including presentations associated with the World Conference on Lung Cancer, the European Society of Thoracic Surgeons, and Turkish thoracic surgery congresses.[9]

Research Contributions

Ömer Yavuz has contributed to research evaluating minimally invasive surgical procedures and thoracic oncological management. His collaborative study on immune profiling after minimally invasive lobectomy examined postoperative immunological responses following thoracic surgical intervention.[10]

Additional research contributions include investigations into thoracic surgical outcomes during the COVID-19 pandemic, demonstrating the feasibility of elective cancer surgery during periods of healthcare system restriction.[11] Other studies addressed prognostic indicators in lung adenocarcinoma, including spread through air spaces identified through PET/CT imaging modalities.[12]

His more recent research activities involve robotic-assisted thoracic surgery, landmark-based port catheter placement techniques, thoracic outlet syndrome procedures, and perioperative management strategies in low-resource surgical settings.[13] Several accepted publications scheduled for 2026 further demonstrate ongoing academic engagement in thoracic surgical innovation and healthcare research productivity.[14]

  • Research in minimally invasive thoracic surgery and robotic-assisted procedures.
  • Clinical investigations in lung cancer surgery and thoracic oncology.
  • Studies involving perioperative outcomes and surgical feasibility during the COVID-19 pandemic.
  • Development of port catheter placement approaches in resource-limited clinical settings.
  • Participation in multidisciplinary and international thoracic surgery collaborations.

Publications

Ömer Yavuz has contributed to thoracic surgery research through publications focused on minimally invasive surgery, thoracic oncology, robotic-assisted procedures, perioperative management, and pulmonary diseases. His scholarly work includes clinical investigations on lung adenocarcinoma, immune profiling after lobectomy, pleurodesis techniques, hyperhidrosis surgery outcomes, and port catheter complications. He has also participated in multidisciplinary and international collaborative studies published in peer-reviewed medical journals, including research related to COVID-19 surgical management and malignant pleural mesothelioma. These publications demonstrate sustained engagement with evidence-based thoracic surgery, innovative surgical methodologies, and contemporary clinical challenges within medicine and health sciences.

Research Impact

The academic contributions of Ömer Yavuz have supported ongoing discussions related to thoracic surgical techniques, perioperative care, robotic-assisted interventions, and oncological thoracic procedures. His Scopus-indexed publication record demonstrates measurable citation activity and participation in collaborative scientific research.[15]

His involvement in educational seminars and professional associations, including the Turkish Thoracic Society, Turkish Society of Thoracic Surgery, and European Society of Thoracic Surgeons, further reflects sustained engagement with academic medicine and surgical education.[16]

  • Peer-reviewed publications indexed in international academic databases.
  • Conference presentations at national and international thoracic surgery congresses.
  • Research participation in EU Framework Program and TÜBİTAK-supported scientific projects.
  • Ongoing publication activity in robotic thoracic surgery and surgical innovation.
  • Academic teaching contributions within thoracic surgery clinical seminars.

Award Suitability

The scholarly record of Ömer Yavuz demonstrates alignment with the objectives of the Excellence in Research Award presented through the Top Teachers Awards platform. His contributions to thoracic surgery research, publication activity in peer-reviewed journals, participation in international congresses, and involvement in educational and collaborative medical initiatives collectively support recognition for academic and professional achievement.[17]

Particular areas of distinction include minimally invasive thoracic surgery, robotic-assisted surgical techniques, thoracic oncology research, and clinical studies concerning perioperative outcomes and surgical methodologies in varying healthcare settings.[18]

Conclusion

Ömer Yavuz has established an academic and clinical profile characterized by ongoing participation in thoracic surgery research, scientific collaboration, and surgical education. His publication history, conference involvement, and clinical specialization reflect continued engagement with evidence-based thoracic surgical practice and medical research development. The breadth of his scholarly contributions within medicine and health sciences provides a substantial basis for recognition through the Excellence in Research Award.[19]

References

    1. Elsevier. (n.d.). Scopus author details: Ömer Yavuz, Author ID 56712503200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56712503200
    2. Başakşehir Çam and Sakura City Hospital. (n.d.). Thoracic surgery and clinical research activities.
    3. Yıldızhan, A., Candaş, F. H., Yavuz, Ö., et al. (2015). Experiences with the Nuss Procedure in Young Adult Patients with Pectus Excavatum.DOI: https://doi.org/10.5606/tgkdc.dergisi.2015.10497
    4. Erus, S., Öztürk, A. B., Albayrak, Ö., et al. (2021). Immune Profiling After Minimally Invasive Lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    5. Marazioti, A., et al. (2021). KRAS Signaling in Malignant Pleural Mesothelioma. DOI: https://doi.org/10.15252/emmm.202013631
    6. Curriculum Vitae of Ömer Yavuz. (2026). Professional experience and academic background.
    7. Süer, H., et al. (2023). Combination of CEACAM5, EpCAM and CK19 Gene Expressions in Mediastinal Lymph Node Micrometastasis. DOI: https://doi.org/10.1186/s13019-023-02297-z
    8. Yavuz, Ö., İşcan, M. (2025). Port Catheter Thickness and Its Correlation with Complications – Exploring the Millimeter Threshold. DOI: https://doi.org/10.1186/s13019-025-03817-9
    9. European Society of Thoracic Surgeons. (2022). Conference proceedings and poster presentations.
    10. Interactive CardioVascular and Thoracic Surgery. (2021). Immune profiling after minimally invasive lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    11. Kulle, C. B., et al. (2021). Is Elective Cancer Surgery Feasible During the Lock-Down Period of the COVID-19 Pandemic? DOI: https://doi.org/10.1002/jso.26436
    12. Falay, O., et al. (2021). Prediction of Spread Through Air Spaces with Preoperative 18F-FDG PET/CT in Primary Lung Adenocarcinoma. DOI: https://doi.org/10.1097/MNM.0000000000001414
    13. İşcan, M., Yavuz, Ö. (2026). Uniportal Robotic-Assisted Thoracic Surgery for Anatomical Lung Resections. DOI: https://doi.org/10.20452/wiitm.2026.18021
    14. Current Thoracic Surgery. (2026). Accepted publications in thoracic surgery and bibliometric analysis.
    15. Scopus Database Metrics. (n.d.). Author citation indicators and publication statistics.
    16. Turkish Thoracic Society; Turkish Society of Thoracic Surgery; European Society of Thoracic Surgeons. (n.d.). Professional membership records.
    17. Top Teachers Awards. (n.d.). Excellence in Research Award recognition framework. https://topteachers.net/
    18. CTSNet. (2024–2025). Robotic thoracic surgery and port catheter publications.
    19. Academic Curriculum Documentation. (2026). Teaching activities, conference participation, and scholarly output.

Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Dr. Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Han Neuro Acupuncture & Herbal Specialist | Malaysia

Dr. Hui Saan Tham is a distinguished practitioner and academic in Chinese Medicine, specializing in acupuncture for complex neurological and spinal disorders. She holds a PhD in Acupuncture from Guangzhou University of Chinese Medicine and serves as Founder and Director of HAN Neuro Acupuncture & Herbal Specialist in Malaysia, a globally recognized center attracting patients from over 50 countries. Dr. Tham pioneered the Micro Perception In-Depth (MPID) and Palpation Guided Acupuncture (PGA) systems, advancing diagnostic precision and clinical outcomes. With multiple peer-reviewed publications and international conference presentations, she actively contributes to research and education. She has held key advisory roles at International Medical University and international committees, promoting curriculum development and professional standards. Her work significantly impacts global healthcare by integrating traditional knowledge with modern clinical and technological innovations.

Google Scholar

Featured Publications

WD Wang, SY Mok, YM Lim, HS Tham, LF Tan, CN Foo, CPY Lim (2026).
Development and Preliminary Evaluation of an EfficientNet-Based Deep Learning System for Ultrasound Assessment of Neck Disorders: A Single-Center Study
Diagnostics | Journal Article · 2026

(2017).
Palpation Methods and Influencing Factors in Acupuncture
Journal of Shandong University of Traditional Chinese Medicine | Journal Article · 2017

Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Dr. Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Hamamatsu University School of Medicine | Bangladesh

Dr. Mohammad Khaja Mafij Uddin is an Associate Scientist in the Infectious Diseases Division at icddr,b, with over 15 years of expertise in mycobacteriology and tuberculosis (TB) diagnostics. His work integrates molecular, microbiological, and immunological approaches to advance TB detection, drug resistance analysis, and biomarker discovery. He has led and contributed to multiple internationally funded projects, including collaborations with organizations in France, Korea, and the USA, focusing on innovative diagnostics such as targeted next-generation sequencing and non-respiratory TB detection. Dr. Uddin has authored several peer-reviewed publications in high-impact journals, contributing significantly to understanding TB transmission dynamics and extrapulmonary TB. He has mentored graduate students and strengthened laboratory capacity, with his research directly supporting improved TB diagnosis and public health outcomes in high-burden settings.

Citation Metrics (Scopus)

94
75
50
25
0

Citations
94

h-index
4

Documents
5

Citations

h-index

Documents

Featured Publications

Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Dr. Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Aristotle University of Thessaloniki | Greece

Dr. Stylianos Bourmpoutelis is an emerging researcher in Internal Medicine whose work is strongly centered on HIV medicine, antimicrobial resistance, and the clinical–microbiological interfaces shaping modern infectious disease care. His research activity reflects a sustained commitment to improving patient outcomes through evidence-based clinical strategies, with particular emphasis on vulnerable populations such as people who inject drugs. His contributions include data collection, clinical evaluation, and outcome-driven analysis that support impactful publications in peer-reviewed journals. Bourmpoutelis has participated in multidisciplinary research networks, contributing to studies that integrate public health, infectious diseases, and microbiology in order to optimize care pathways and improve treatment adherence. His scholarly visibility continues to grow through citations in reputable databases and the ongoing expansion of his indexed publications. He maintains active research profiles and consistently updates citation-related documents to ensure transparency and accessibility for the scientific community. Current citation metrics include an estimated Scopus h-index of 2 and a Google Scholar h-index of 3, reflecting the early yet steadily increasing influence of his work. His documented contributions demonstrate strong methodological engagement, rigorous data interpretation, and a readiness to collaborate across clinical and scientific teams. Bourmpoutelis’s research record aligns with the ideals of the Young Scientist Award, showcasing innovation, academic promise, and meaningful contributions to public health research. His scientific outputs emphasize integrated care models, real-world clinical outcomes, and microbiological investigations that collectively advance understanding within internal medicine and infectious disease research. With a growing portfolio of indexed publications and documented research contributions, he continues to establish himself as a dedicated early-career scientist advancing impactful, ethically grounded, and methodologically robust medical research.

Publication Profile

Google Scholar

Featured Publications

Roussos, S., Protopapapas, K., Mastrogianni, E., Totsikas, C., Moschopoulos, C. D., Bourmpoutelis, S., Resta, P., Procter, K., Kokolesis, E., Antoniadou, A., et al. (2025). Rapid ART initiation with BIC/FTC/TAF in people who inject drugs in Greece: Results from a pilot single-arm study of an integrated care model. Microorganisms, 13(12), 2697.